Policy: Component Processing 24th Jul 20215th Jun 2021 drzeyd Enumeration: 5.8 Policy: All processing will be in accordance with good manufacturing practices.All testing will follow manufacturer’s recommended testing methods.The specific processing algorithms will be programmed into the Hematos IIG software.Validation of the processing will be performed by Hematos IIG, which will control final ISBT labellingAll abnormal results will be reviewed by a transfusion medicine physician.All policies, processes, and procedures must comply with Qatari, HMC, and applicable accreditation standards (i.e. AABB, CAP, and JCI). References: HMC 1001 Setting Specification, Version 1.5, Hematos IIG, MedinfoStandards for Blood Banks and Transfusion Services, Current Edition, AABB, Bethesda, Maryland, USA
Dealing with Rare Blood Groups: Part 3 22nd Jul 20213rd Jun 2021 drzeyd This is an updated version of a previous post.
Dealing with Rare Blood Groups: Part 2 21st Jul 20213rd Jun 2021 drzeyd This is a revised version of a previous post.
Dealing with Rare Blood Groups: Part 1 20th Jul 20211st Jun 2021 drzeyd This is an updated version of a previous post.